Evaluation and comparison of five experimental BPH/prostate cancer treatment modalities

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 10297, Issue , 2000, Pages 519-545

  Hoopes, P J ^a,b   Wishnow, K A ^c   Bartholomew, Luanna R ^a   Jonsson, E ^d   Williams, J C ^e   Moodie, Karen L ^a   Wong, Terence Z ^f   Harris, R D ^a   Ryan, Thomas P ^g   Trembly, B Stuart ^b   McNicholas, Thomas A ^h   Heaney, J A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Thayer Engineering School   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d Reykejvik Hospital   (Iceland)

^e UNIVERSITY OF FLORIDA   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g ETHICON INC   (United States)

^h LISTER HOSPITAL   (United Kingdom)

Author keywords

Cancer; Cryotherapy; Dog; Experimental; Hyperplasia; Hyperthermia; Laser; Prostate; Stent; Treatment

Indexed keywords

CRYOTHERAPY; DISEASES; HYPERTHERMIA THERAPY; LASERS; PHYSICAL THERAPY;

CANCER; EXPERIMENTAL; HYPERPLASIA; HYPERTHERMIA; PROSTATE; STENT; TREATMENT;

UROLOGY;

EID: 0004559590     PISSN: 0277786X     EISSN: 1996756X     Source Type: Conference Proceeding    
DOI: 10.1117/12.375221     Document Type: Conference Paper

References (24)

1. Guess HA. The epidemiology and natural history of benign prostatic hyperplasia. IN Handbook on Benign Hyperplasia, GD Chisholm (ed). Merck & Co, NJ, pp. 1-18, 1994.
2. Nielson SW, Kennedy PC. Tumors of the genital system. IN Tumors in Domestic Animals, JE Moulton (ed). University CA Press, Berkeley, pp. 491-495, 1990.
3. Lee, Torp-Petersen, Siders. The role of TRUS in early detection of prostaate cancer. CA-A Cancer Journal for Clinicians. American Cancer Society, NY, pp. 347-350, 1989.
4. Habib FK. Pathogenesis of benign prostatic hyperplasia. IN Handbook on Benign Hyperplasia, GD Chisholm (ed). Merck & Co, NJ, pp. 19-31, 1994.
5. Kaplan SA, Dowd JB. Non-pharmacologic alternative therapy in the management of benign prostatic hyperplasia. IN Handbook on Benign Hyperplasia, GD Chisholm (ed). Merck & Co, NJ, pp. 115-136, 1994.
6. Mebust MK. Transurethral surgery. IN Campbell's Urology, PC Walsh, et al., (eds). Saunders, Philadelphia, pp. 2911-2922, 1992.
7. Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA-A Cancer Journal for Clinicians. American Cancer Society, NY, pp. 8-30, 1995.
8. Hanno PM. Carcinoma of the prostate. IN Current Urologic Therapy, EJ Seidmon, PM Hanno (eds). WB Saunders, Philadelphia, pp. 384-386, 1994.
9. Heaton P. Radiofrequency thermal ablation of the prostate: The TUNA technique. Techniques Urology, 1(1):3-10, 1995.
10. Dawkins GP, Harrison NW, Ansell W. Radiofrequency heat treatment to the prostate for bladder outlet obstruction associated with benign prostate hyperplasia: A 4-year outcome study. British J Urology, 79(6):910-914, 1997.
11. Yoshida O, Terai A, Shichiri Y, et al. Transurethral radiofrequency thermotherapy for benign prostatic hyperplasia: Preliminary clinical results. International J Urology, 3(6):454-458, 1996.
12. D'Ancona FC, Albers YH, Klemeney LA, et al. Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study. Prostate, 40(l):28-36, 1999.
13. Eliasson T, Abramsson L, Damber JE. Importance of thermal dose and antenna location in transurethral microwave thermotherapy for benign prostatic hyperplasia. J Endourology, 12(6):581-589, 1998.
14. D'Ancona FC, Francisca EA, Hendriks JC, et al. The predictive value of baseline variables in the treatment of benign prostatic hyperplasia using high-energy transurethral microwave thermotherapy. British J Urology, 82(6):808-813, 1998.
15. Barbalias CA, Liatsikos FN. Transrectal microwave hyperthermia for patients with benign prostatic hyperplasia. International J Urology, 5(2):157-162, 1998.
16. Stawarz B, Zielinski H, Szmigielski S, et al. Transrectal hyperthermia as palliative treatment for advanced adenocarcinoma of the prostate and cell-mediated immunity. Urology, 41(6):548-553, 1993.
17. Mc Nicholas TA, Steger AC, Brown SG. Interstitial laser coagulation of the prostate: An experimental study. British J Urology, 71:439, 1993.
18. Littrup PJ, Lee F, Borlaza GS, et al. Percutaneous ablation of canine prostate using transrectal ultrasound guidance: Absolute ethanol and Nd:YAG laser. Invest Radiol, 23:734-739, 1988.
19. Perlmutter AP, Muschter R. Interstitial laser prostatectomy. Mayo Clinic Proceedings, 73(9):903-907, 1998.
20. Onik G, Porterfield B, Rubinsky B, et al. Percutaneous transperineal prostate cryosurgery using transrectal ultrasound guidance: Animal model. Urology, 37:277-281, 1991.
21. Kunit G. Open-perineal-cryosurgery in carcinoma of the prostate-A possible curative alternative. Urology Research, 14:3-7, 1986.
22. Miller RS, Cohen JK, Merlotii LA. Percutaneous transperineal cryosurgical ablation of the prostate for primary treatment of clinical stage C adenocarcinoma of the prostate. Urology, 44(2): 170-174, 1994.
23. Peterson DS, Milleman LA, Rose EF, et al. Biopsy and clinical course after cryosurgery for prostate cancer. J Urology, 120(3):308-311, 1978.
24. Gage AA. Cryosurgery in the treatment of cancer. Surgery Gynecol. Obstetrics, 174(l):73-92, 1992.